Tech Company Financing Transactions
Neok Bio Funding Round
Neok Bio closed a $75 million Series A investment round on 11/5/2025. Backers included ABL Bio and private investors.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Palo Alto, CA Undisclosed
USA
Palo Alto, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At NEOK Bio, we're driven to fulfill the vast, untapped potential of the ADC modality in oncology to rapidly and efficiently deliver transformative therapeutic benefits to cancer patients. Backed by ABL Bio, a pioneer and world-leader in antibody engineering via its advanced technology platform, NEOK is well-positioned to deliver cutting-edge, dual target ADCs that overcome the efficacy and safety challenges that have limited the effectiveness of conventional ADC therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mayank Gandhi
Browse more venture capital transactions:
Prev: 11/5/2025: The Icon League venture capital transaction
Next: 11/5/2025: CommanderAI venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs